Ignite Creation Date:
2025-12-24 @ 4:05 PM
Ignite Modification Date:
2026-02-23 @ 1:11 AM
Study NCT ID:
NCT03628066
Status:
COMPLETED
Last Update Posted:
2022-04-20
First Post:
2018-07-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer
Sponsor:
NSABP Foundation Inc
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Breast Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Ovarian Suppression | View |
| None | Neoadjuvant | View |
| None | Premenopausal | View |
| None | Estrogen-Receptor Positive | View |
| None | HER2-Negative | View |
| None | Primary | View |
| None | Palbociclib | View |
| None | Letrozole | View |
| None | Goserelin | View |
| None | Ki67 | View |
| None | Oncotype DX Breast Recurrence Score | View |
| None | Open-Label | View |